EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis

Gareth Parkes, Ryan C Ungaro, Silvio Danese, Maria T Abreu, Ethan Arenson, Wen Zhou, Dapo Ilo, F Stephen Laroux, Huiwen Deng, Yuri Sanchez Gonzalez, Laurent Peyrin-Biroulet

Journal of Gastroenterology · 2023-10 · 58 (10) · 990-1002

DOI: 10.1007/s00535-023-02013-7 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Gastroenterology, online erschienen am 25.07.2023. Verfasst von Gareth Parkes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dept of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK. gareth.parkes@nhs.net. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We evaluated the clinical relevance of achieving histologic endoscopic mucosal improvement (HEMI) and the more stringent target of histologic endoscopic mucosal remission (HEMR) in the phase 3 maintenance trial of upadacitinib for moderately to severely active ulcerative colitis.

Methods

Clinical and patient-reported outcomes were assessed in patients with clinical response after 8- or 16-week upadacitinib induction who received 52-week upadacitinib maintenance treatment. Cross-sectional and predictive analyses evaluated the relationship between HEMR or HEMI at Week 8/16 and Week 52, respectively, and outcomes at Week 52. Adjusted odds ratios (aOR) were derived from logistic regressions for patients achieving HEMR or HEMI without HEMR versus those not achieving HEMI.

Results

Cross-sectional analyses showed that patients with HEMR had greater odds of achieving all clinical and patient-reported outcomes at Week 52 than those not achieving HEMI. In predictive analyses, patients with HEMR at Week 8/16 had significantly greater odds of achieving clinical remission (aOR = 3.6, p = 0.001) and endoscopic remission (aOR = 3.9, p < 0.001) at Week 52 than patients not achieving HEMI and HEMR. For patients achieving HEMI without HEMR, these odds were lower: clinical remission (aOR = 3.2, p < 0.001) and endoscopic remission (aOR = 2.4, p = 0.010). The odds of achieving clinically meaningful improvements in most patient-reported outcomes were directionally similar between HEMI and HEMR, but not statistically different to patients not achieving HEMI. No hospitalizations or surgeries were observed in patients with HEMR at Week 52.

Conclusions

Achievement of HEMR or HEMI is clinically relevant with HEMR being associated with greater likelihood of improvement in long-term clinical and patient-reported outcomes. https://www.clinicaltrials.gov NCT02819635.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHumansCross-Sectional StudiesEndoscopyIntestinal MucosaRemission InductionSeverity of Illness IndexTreatment Outcome

Stichwörter der Autor:innen

Histologic endoscopic mucosal improvementHistologic endoscopic mucosal remissionInflammatory bowel disease

Autor:innen und Institutionen

  • Dept of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK. gareth.parkes@nhs.net.
  • Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
  • Division of Gastroenterology, Crohn's and Colitis Center, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Adelphi Values, Boston, MA, USA.
  • AbbVie Inc., Chicago, IL, USA.

Förderung

  • NIDDK NIH HHS
  • AbbVie

Zitieren

APA

Parkes, G., Ungaro, R. C., Danese, S., Abreu, M. T., Arenson, E., Zhou, W., Ilo, D., Laroux, F. S., Deng, H., Sanchez Gonzalez, Y., & Peyrin-Biroulet, L. (2023). Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis. Journal of Gastroenterology, 58(10), 990-1002. https://doi.org/10.1007/s00535-023-02013-7

Vancouver

Parkes G, Ungaro RC, Danese S, Abreu MT, Arenson E, Zhou W, et al. Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis. Journal of Gastroenterology. 2023;58(10):990-1002. doi:10.1007/s00535-023-02013-7

BibTeX
@article{Parkes2023,
  author = {Parkes, Gareth and Ungaro, Ryan C and Danese, Silvio and Abreu, Maria T and Arenson, Ethan and Zhou, Wen and Ilo, Dapo and Laroux, F Stephen and Deng, Huiwen and Sanchez Gonzalez, Yuri and Peyrin-Biroulet, Laurent},
  title = {Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis},
  journal = {Journal of Gastroenterology},
  year = {2023},
  volume = {58},
  number = {10},
  pages = {990--1002},
  doi = {10.1007/s00535-023-02013-7}
}
Kostenlos starten →